There is an error in the second sentence of the Subjects and Methods section. The correct sentence is: This was defined as the state of 2.6 \< DAS28ESR \< 5.1 or PD score ≥ 2 in at least one of the 28 joints on US examination.

There is an error in the fourth sentence of the fifth paragraph of the Discussion section. The correct sentence is: Therefore, the effects of bDMARDs on the serum MMP-3 levels could not be evaluated accurately.

There is an error in the first sentence of the eighth paragraph of the Discussion section. The correct sentence is: According to a report by Hattori et al. analyzing 114 RA patients treated with adalimumab for 52 weeks or longer, the rate of improvement of the serum MMP-3 levels after 4 weeks was significantly higher in the DAS28-CRP remission group.

In [Fig 3](#pone.0211750.g001){ref-type="fig"}, the headings PSL using and PSL non-using are swapped. The left side should be PSL non-using and the right should be PSL using. Please see the corrected [Fig 3](#pone.0211750.g001){ref-type="fig"} here.
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